Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shandong Linuo Pharmaceutical Co., Ltd. is a prominent Chinese pharmaceutical company and a key subsidiary of the Linuo Group. Headquartered in Jinan, Shandong Province, the company integrates drug research, production, and sales, focusing on both chemical pharmaceuticals and traditional Chinese medicine. Its product portfolio covers a wide range of therapeutic areas, including hepatology, dermatology, gastroenterology, and respiratory health, with flagship products like Compound Glycyrrhizin. The company operates modern, GMP-certified manufacturing facilities and maintains a significant presence in the Chinese domestic market while expanding its international reach. It is recognized for its high-tech approach to drug formulation and its commitment to quality standards in the production of tablets, capsules, and injections.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shandong Linuo Pharmaceutical.